Research programme: venom-derived molecules - Cytopia/Xenome

Drug Profile

Research programme: venom-derived molecules - Cytopia/Xenome

Alternative Names: Venom-derived molecules research programme - Cytopia/Xenome

Latest Information Update: 30 Sep 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cytopia Research; Xenome
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Inflammation

Most Recent Events

  • 30 Sep 2004 Cytopia and Xenome have completed their collaboration
  • 17 Oct 2002 Preclinical trials in Cancer in Australia (unspecified route)
  • 17 Oct 2002 Preclinical trials in Inflammation in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top